Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats
about
Cathinone neurotoxicity ("The "3Ms")Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in ratsPharmacological characterization of designer cathinones in vitroSubstituted methcathinones differ in transporter and receptor interactionsEffect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley ratsThe preclinical pharmacology of mephedrone; not just MDMA by another name.In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Intravenous self-administration of entactogen-class stimulants in male ratsNeuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsNovel Drugs of Abuse: A Snapshot of an Evolving Marketplace.Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.Behavioral pharmacology of designer cathinones: a review of the preclinical literature3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats.Intravenous self-administration of mephedrone, methylone and MDMA in female rats.Synthetic cathinones: a new public health problemBath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male ratsAbuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanismPsychoactive "bath salts": not so soothing.Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in ratsPowerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsStereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation.Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats.The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.Bath salts and synthetic cathinones: an emerging designer drug phenomenon.Neuronal extracellular signal-regulated kinase (ERK) activity as marker and mediator of alcohol and opioid dependence.Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats.Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats.Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone).
P2860
Q26828641-B28269A2-7720-44E0-98E4-AB2EAFDEAF67Q27324932-52124C2F-91AE-465D-80AF-2DA7EC18C1BDQ28273207-EFBB072A-8CA7-4EF4-A819-1FC20D7A6823Q28288908-4935D491-6EC2-49A4-84B7-E7485C6B9EEDQ28483306-0D79E7D7-096A-450E-8A50-FB86ADD20DA6Q30412911-3D60EF92-FC66-4627-A944-E86C82B2EF4CQ30535782-87D7F267-0FA8-435F-B756-8724ECF90F18Q30680394-3B86FB34-752C-4C55-B567-ACC301C96512Q33566201-6AD9F30A-DEC5-477C-87E8-613F2CACDF35Q33725088-E5585FDC-33FA-483C-AA40-7E1CB3EF9E34Q34280393-8C815179-8741-4554-BA37-B712A198285DQ34385074-E331AFC7-543D-4BCA-BF69-B2347448ACC6Q34459984-6155F0EE-B87D-4C1C-9689-6DCED69D732EQ34941985-30DE45EC-A26B-492C-928F-24D1FCCAFB50Q35137747-5C29FC49-645E-4125-99A0-A88DF86B4D69Q35710543-B18B2E5B-C2F3-4DED-A3C0-361FB430007FQ35754464-3182068D-095D-4449-B61A-AD52EE5DE404Q35889508-F026132F-F77D-423B-BADE-77571F59DD50Q36056252-9D39BD21-5CD2-4685-84B5-C46F331489C8Q36194433-0A7F3F0B-DC84-4184-9F27-DEE5709D7CB0Q36509367-C02F6ECB-D3D1-4A62-A9C6-F0BDC8FFB151Q36510321-6533A2CE-D0D2-4C11-82C9-800F4C6E34F0Q36579253-3784AC7F-E66B-4258-A496-EBE6C57C304CQ36610017-1CB1FCDA-DD98-4AF1-9028-B5C43E3ED12FQ36618734-DDBE1BAE-EB25-4DF7-A8DC-F7CF214FA21DQ36709254-3C33EEBA-7DD9-4779-84B4-EB4EAAFFACF9Q36809051-4A56E983-62A6-44A8-842A-C5C9C5EF7808Q36926811-084F9274-599A-40E1-BB65-1BB3B33DC0B2Q37540813-108F3BF0-4ED4-4548-8A8E-BA5665AC1E22Q37629743-7952889A-9962-4D22-8F5B-4E25985F2FD1Q37685951-76981E98-FAEF-468A-A1B6-2177498AC999Q37706820-F51512D6-7871-41D7-B2DD-CEF9CB7A03D7Q37718575-6D32E716-5455-408E-B1C1-65CA3C28C690Q38622274-EB8A44B9-FE63-4F47-AAAC-021170C2B2DAQ38788193-2B8B770C-513A-4F86-A819-984C4A7CDF9CQ38824564-FEABCFBB-DD68-40F4-93BD-61356C0AC44DQ39026719-1B2FA621-0E82-4B3C-AFC2-856E0BA02E1DQ39107792-6308AEE8-0EE0-449B-B6C5-C60896DDE250Q39699950-B971ABCE-5980-4186-9562-4A5DE715CC04Q41439587-C71E624F-B7A4-43F3-814A-B30149458451
P2860
Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Contrasting effects of d-metha ...... none on wheel activity in rats
@ast
Contrasting effects of d-metha ...... none on wheel activity in rats
@en
type
label
Contrasting effects of d-metha ...... none on wheel activity in rats
@ast
Contrasting effects of d-metha ...... none on wheel activity in rats
@en
prefLabel
Contrasting effects of d-metha ...... none on wheel activity in rats
@ast
Contrasting effects of d-metha ...... none on wheel activity in rats
@en
P2093
P2860
P1476
Contrasting effects of d-metha ...... none on wheel activity in rats
@en
P2093
Deepshikha Angrish
Karen L Houseknecht
Michael A Taffe
Pai-Kai Huang
Shawn M Aarde
Tobin J Dickerson
P2860
P304
P356
10.1016/J.DRUGALCDEP.2012.05.011
P577
2012-06-03T00:00:00Z